Candidiasis: all 270 studies

Page 3 of 3. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and ToddlersCompletedNCT00797420Phase 1
• Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?CompletedNCT00786903
• Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation TherapyCompletedNCT00768794Not applicable
• Comparative Efficacy of Ovule vs TabletCompletedNCT00755053Phase 3
• Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole SusceptibilityTerminatedNCT00692783
• CRITIC - Treatment of Candidemia and Invasive CandidiasisCompletedNCT00670657Phase 4
• Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal CandidiasisCompletedNCT00666185Phase 3
• Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCompletedNCT00665639Phase 3
• A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal InfectionsCompletedNCT00647907Phase 4
• Novel Rinse to Treat in Oral Candidiasis in Cancer PatientsCompletedNCT00612963
• Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00608335Phase 1
• Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00607763Phase 1
• Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in TanzaniaCompletedNCT00553137Phase 4
• Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a WeekStatus unknownNCT00537888Phase 4
• Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast VaginitisStatus unknownNCT00479947Phase 1
• Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal InfectionCompletedNCT00388167
• Changing Patterns of Candida Infections in Urban Medical CentersCompletedNCT00366223
• Diabetes Mellitus and Vulvovaginal CandidiasisCompletedNCT00353561Phase 3
• Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)CompletedNCT00330395Phase 2
• Study of the Management of Vaginal Discharge in West African Using Single Dose TreatmentsCompletedNCT00313131Phase 3
• Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic PatientsWithdrawnNCT00304772Phase 4
• Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BIDCompletedNCT00235053Phase 4
• Efficacy Vulvovaginitis CandidaTerminatedNCT00199264Phase 2
• Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the VaginaCompletedNCT00194324Phase 4
• Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and CandidemiaCompletedNCT00189709Phase 3
• A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.CompletedNCT00163111Phase 3
• Funguria in Hospitalized PatientsCompletedNCT00138502
• A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal CandidiasisCompletedNCT00128323Phase 3
• Early Diagnosis of Candidiasis in Premature InfantsCompletedNCT00109525
• Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaCompletedNCT00106288Phase 3
• Study of Micafungin in Patients With Invasive Candidiasis or CandidemiaCompletedNCT00105144Phase 3
• Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care UnitsCompletedNCT00099775Phase 3
• Caspofungin Study for Fungal Infections in Adults in Critical Care SettingsTerminatedNCT00095316Phase 3
• Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)CompletedNCT00083343Phase 2
• Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)CompletedNCT00082524Phase 2
• Anidulafungin Versus Fluconazole in the Treatment of CandidemiaCompletedNCT00058682Phase 3
• The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisCompletedNCT00056368Phase 3
• The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)CompletedNCT00041704Phase 2
• The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.CompletedNCT00037219Phase 2
• Study of FK463 in the Treatment of Candidemia or Invasive CandidiasisCompletedNCT00036179Phase 2
• A Study of the Side Effects of L-743,872 in Men With Candidal EsophagitisCompletedNCT00005921Not applicable
• Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With FluconazoleTerminatedNCT00005920Phase 2
• Voriconazole to Prevent Systemic Fungal Infections in ChildrenCompletedNCT00005912Phase 1
• Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk GroupsCompletedNCT00004781
• Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive PatientsCompletedNCT00002446Phase 3
• The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected PatientsCompletedNCT00002431Not applicable
• A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive PatientsCompletedNCT00002399Phase 2
• Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole TreatmentCompletedNCT00002394Not applicable
• A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With FluconazoleCompletedNCT00002341Not applicable
• A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsCompletedNCT00002339Phase 3
• A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsCompletedNCT00002304Not applicable
• A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related SyndromesCompletedNCT00002293Not applicable
• A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDSCompletedNCT00002282Not applicable
• An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.CompletedNCT00002133Not applicable
• Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.CompletedNCT00002132Not applicable
• Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency SyndromeCompletedNCT00002112Not applicable
• Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARCCompletedNCT00002057Not applicable
• Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised PatientsCompletedNCT00002041Not applicable
• Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal TherapyCompletedNCT00002038Not applicable
• Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant PatientsCompletedNCT00001937Phase 3
• A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2CompletedNCT00001812Phase 3
• An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001810Phase 3
• Fluconazole Prophylaxis of Thrush in AIDSCompletedNCT00001542Phase 4
• The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV InfectionCompletedNCT00001448
• Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver TransplantsCompletedNCT00001107Phase 4
• A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With FluconazoleCompletedNCT00001065Phase 2
• A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent ThrushCompletedNCT00000951Phase 4
• A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of MethadoneCompletedNCT00000788Phase 1
• A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected WomenCompletedNCT00000744Not applicable
• Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)CompletedNCT00000676Phase 3

← Candidiasis overview